The PCDH11X Gene Dyslexia Genetic Test is a specialized diagnostic tool designed to identify genetic markers associated with dyslexia, specifically focusing on the PCDH11X gene located on the X chromosome. This gene has been implicated in neurological development and is thought to play a crucial role in the development of dyslexia, a common learning disorder characterized by difficulties in reading despite normal intelligence and adequate instruction.
Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, the test offers individuals and families insights into the genetic underpinnings of dyslexia, potentially aiding in early detection and the implementation of targeted educational strategies and interventions. The test involves collecting a DNA sample, typically through a simple and non-invasive saliva or blood sample, which is then analyzed for specific genetic variations in the PCDH11X gene that are linked to dyslexia.
The cost of the PCDH11X Gene Dyslexia Genetic Test at DNA Labs UAE is 4400 AED. This investment includes the comprehensive analysis of the genetic sample, a detailed report of the findings, and, in some cases, a consultation to discuss the results and their implications. By identifying a genetic predisposition to dyslexia, parents, educators, and healthcare providers can work together to support individuals with dyslexia, tailoring learning approaches to their unique needs and helping them to achieve their full academic potential.
The HSPG2 gene dyssegmental dysplasia Silverman-Handmaker type genetic test is a specialized diagnostic tool designed to identify mutations in the HSPG2 gene, which are responsible for causing dyssegmental dysplasia Silverman-Handmaker type. This rare genetic disorder is characterized by severe skeletal abnormalities that affect the development of the ribs and limbs, leading to significant physical impairments. The condition is inherited in an autosomal recessive pattern, meaning that both copies of the gene in each cell have mutations.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any mutations in the HSPG2 gene. This test is crucial for accurate diagnosis and can also be used for carrier testing in individuals with a family history of the condition, as well as for prenatal diagnosis.
The cost of the HSPG2 gene dyssegmental dysplasia Silverman-Handmaker type genetic test at DNA Labs UAE is 4400 AED. While the price may seem steep, the test provides invaluable information for affected individuals and their families, offering insights into the condition and informing decisions regarding management and care. Early and precise diagnosis through genetic testing can significantly impact the quality of life for those with dyssegmental dysplasia Silverman-Handmaker type and assist healthcare providers in developing the most appropriate treatment plans.
The ACTB Gene Dystonia Juvenile-Onset Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ACTB gene that are associated with the early onset of dystonia. Dystonia is a movement disorder characterized by involuntary muscle contractions, leading to repetitive movements or abnormal postures. The ACTB gene plays a crucial role in the production of beta-actin, a protein essential for cell structure and integrity, and mutations in this gene can disrupt normal muscle function and lead to dystonia.
This genetic test is particularly important for individuals showing symptoms of dystonia at a young age, as early detection can significantly impact the management and treatment options available. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the ACTB gene that are known to cause juvenile-onset dystonia.
DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The test not only aids in the accurate diagnosis of dystonia but also helps in understanding the genetic predisposition of the condition, enabling families to make informed decisions regarding future family planning. The results from this test can also provide valuable information for personalized treatment plans, improving the quality of life for those affected by this challenging condition.
The SPR Gene Dystonia DOPA-Responsive Autosomal Recessive Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SPR gene that are known to cause DOPA-responsive dystonia. This condition is a rare, inherited neurological disorder characterized by muscle contractions leading to repetitive movements or abnormal postures. These symptoms are notably responsive to treatment with DOPA, a precursor to dopamine, which is a neurotransmitter involved in controlling movement. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect specific genetic alterations in the SPR gene, which plays a critical role in dopamine biosynthesis. Identifying these mutations can confirm a diagnosis of DOPA-responsive dystonia, enabling healthcare providers to recommend the most effective treatment strategies. Conducted at DNA Labs UAE, this genetic test is a vital resource for individuals experiencing symptoms of dystonia seeking a definitive diagnosis and tailored treatment plan.
The TIMM8A gene dystonia-deafness syndrome, also known as Mohr-Tranebjaerg syndrome, is a rare genetic disorder characterized by progressive hearing loss, dystonia, visual impairment, and neurological decline. The condition is inherited in an X-linked recessive pattern, affecting primarily males, though female carriers may exhibit some symptoms.
To diagnose this condition, a specific genetic test targeting the TIMM8A gene can be conducted. DNA Labs UAE offers this specialized test, designed to detect mutations in the TIMM8A gene that are responsible for the syndrome. The test is crucial for accurate diagnosis, enabling early intervention and management strategies to alleviate symptoms and improve quality of life for affected individuals.
The cost of the TIMM8A gene dystonia-deafness syndrome genetic test at DNA Labs UAE is 4400 AED. This price includes the genetic analysis and a comprehensive report, which provides detailed insights into the individual's genetic makeup concerning the TIMM8A gene. The test is conducted with a high level of accuracy, using advanced genomic technologies to ensure reliable results. Families with a history of the syndrome or individuals showing symptoms are encouraged to consider this test for a definitive diagnosis and to inform potential treatment paths.
The TOR1A gene DYT1 genetic test is a specialized diagnostic tool used for identifying mutations in the TOR1A gene, which are associated with DYT1 early-onset dystonia. Dystonia is a movement disorder characterized by involuntary muscle contractions, resulting in twisting and repetitive movements or abnormal postures. The DYT1 form of dystonia typically manifests in childhood or adolescence and can significantly impact the quality of life.
This genetic test is crucial for individuals showing symptoms of dystonia, as it can confirm the presence of the specific genetic mutation responsible for DYT1 dystonia. Early diagnosis through the TOR1A gene DYT1 genetic test enables timely intervention and management strategies to alleviate symptoms and improve patient outcomes.
The test is available at DNA Labs UAE, a leading facility for genetic testing and analysis. The cost of the TOR1A gene DYT1 genetic test at DNA Labs UAE is 4400 AED. The facility ensures accurate and reliable testing, conducted by experienced professionals, making it a trusted choice for individuals and families seeking clarity on genetic conditions related to dystonia.
The PRRT2 Gene DYT10 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the PRRT2 gene, which are linked to DYT10 (also known as Paroxysmal Kinesigenic Dyskinesia or PKD). This condition is characterized by sudden, brief, involuntary movements or spasms triggered by sudden movements. The test is particularly important for individuals showing symptoms of PKD or those with a family history of the condition, as it can provide a definitive diagnosis and guide treatment and management strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the PRRT2 Gene DYT10 Genetic Test involves collecting a DNA sample, typically through a blood draw or cheek swab. The sample is then analyzed using advanced genetic sequencing techniques to detect any mutations in the PRRT2 gene that are indicative of DYT10.
The cost of the test is 4400 AED, which reflects the comprehensive nature of the genetic analysis and the expertise required to interpret the results. While the price may seem high, the value of a precise diagnosis cannot be understated, as it opens the door to targeted treatments and interventions that can significantly improve the quality of life for individuals affected by this condition.
Overall, the PRRT2 Gene DYT10 Genetic Test is a crucial tool in the diagnosis and management of Paroxysmal Kinesigenic Dyskinesia, providing patients and their families with the answers they need to navigate this challenging condition.
The SGCE Gene DYT11 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the SGCE gene, which are implicated in the development of Myoclonus-Dystonia (M-D), a neurological disorder characterized by rapid, involuntary muscle jerking (myoclonus) and dystonia, which involves abnormal muscle postures. This condition is often inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder, though reduced penetrance is observed, meaning not all individuals with the mutation will exhibit symptoms.
DNA Labs UAE offers this comprehensive genetic test to individuals who are showing symptoms of Myoclonus-Dystonia or have a family history of the disorder, providing a crucial tool for accurate diagnosis and subsequent management. By analyzing the patient's DNA for specific mutations in the SGCE gene, healthcare providers can confirm the diagnosis, understand the risk of passing the condition to offspring, and tailor treatment plans to manage symptoms effectively.
The cost of the SGCE Gene DYT11 Genetic Test at DNA Labs UAE is 4400 AED, reflecting the sophisticated technology and expertise required to perform this intricate analysis. This investment in health allows for a proactive approach in managing the condition, potentially improving the quality of life for those affected by Myoclonus-Dystonia.
The DRD2 gene, associated with the dopamine D2 receptor, plays a critical role in the brain's dopaminergic system, influencing various neurological functions. Mutations or variations in this gene have been linked to several disorders, including DYT11, a condition characterized by myoclonus-dystonia. This genetic disorder involves involuntary muscle jerking (myoclonus) and dystonia, leading to repetitive muscle contractions resulting in twisting and abnormal postures.
The DRD2 Related Genetic Test is a specific diagnostic tool aimed at identifying mutations in the DRD2 gene that are connected to DYT11. Conducted at DNA Labs UAE, this test is pivotal for individuals displaying symptoms of myoclonus-dystonia or those with a family history of the condition, providing crucial information for diagnosis, treatment planning, and genetic counseling.
The test is priced at 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive insights it offers into the patient's genetic makeup regarding the DRD2 gene. By opting for this test, patients and healthcare providers can make informed decisions regarding the management of conditions related to DRD2 gene mutations, potentially improving quality of life and outcomes for those affected.
The ATP1A3 gene DYT12 genetic test is a specialized diagnostic tool designed to identify mutations in the ATP1A3 gene, which are linked to DYT12, also known as Rapid-Onset Dystonia-Parkinsonism. This condition is characterized by the sudden development of dystonia—a disorder that causes involuntary muscle contractions, leading to abnormal postures and movements—accompanied by symptoms of Parkinsonism such as tremors, bradykinesia, and rigidity. The test plays a crucial role in the accurate diagnosis and management of the condition, enabling healthcare providers to tailor treatment plans effectively.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to detect any abnormalities or mutations in the ATP1A3 gene. The process is known for its accuracy and reliability, making it a valuable asset in the field of medical genetics.
The cost of the ATP1A3 gene DYT12 genetic test at DNA Labs UAE is set at 4400 AED. While the price may seem high, the test offers invaluable insights into the genetic underpinnings of DYT12, facilitating early intervention and potentially improving the quality of life for those affected by this rare condition.
